Dow Down0.25% Nasdaq Up0.22%

Navidea Biopharmaceuticals, Inc (NAVB)

-ASE
1.39 Down 0.04(3.02%) 3:06PM EDT - Nasdaq Real Time Price
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Net Income (7,612) (14,351) (13,752) (11,306)
Operating Activities, Cash Flows Provided By or Used In
Depreciation319  353  348  344  
Adjustments To Net Income1,077  2,922  620  1,150  
Changes In Accounts Receivables100  564  (993)17  
Changes In Liabilities(18)(1,468)3,030  8  
Changes In Inventories208  119  (190)(713)
Changes In Other Operating Activities116  79  (218)794  
Total Cash Flow From Operating Activities (8,420) (9,172) (11,155) (9,705)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(123)(986)(477)(91)
Investments -   -   -   -  
Other Cash flows from Investing Activities(7)(7)(24)(11)
Total Cash Flows From Investing Activities (130) (993) (501) (102)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -   -  
Sale Purchase of Stock33  55  (36)28,951  
Net Borrowings(13)3,249  (1)1,028  
Other Cash Flows from Financing Activities(5)(71) -   -  
Total Cash Flows From Financing Activities 15   3,232   (37) 28,802  
Effect Of Exchange Rate Changes -   -   -   -  
Change In Cash and Cash Equivalents (8,535) (6,933) (11,694) 18,994  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.